arrow
M

Murat Araz

Necmettin Erbakan University
H指数:11
被引数:592

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma

avelumab维持治疗转移性尿路上皮癌的预后因素

2026-09-020
OA
Treatment Sequencing of CDK4/6 Inhibitors in Bone-Only Hormone Receptor-Positive Metastatic Breast Cancer: Multi-Center Real-World Data Revealing a Numerical Trend Favoring Later-Line Use

CDK4/6抑制剂在仅骨转移激素受体阳性转移性乳腺癌中的治疗顺序:多中心真实世界数据揭示倾向于晚期使用 numerical 趋势

Cancers
IF4.4
2026-08-280
OA
Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study (TOG/GI-SAFRADJU-2501)

切除后胆道癌的辅助化疗方案:国家性、比较性、观察性研究(TOG/GI-SAFRADJU-2501)

2026-08-150
OAAI
Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study

RAS野生型转移性结直肠癌中HER2表达的临床预后和治疗特异性预测意义:一项多中心回顾性真实世界研究

2026-05-220
OA
Does the Duration of FLOT Infusion Change the Outcome of Perioperative Treatment for Gastric Cancer? Comparing 24-and 48-h Infusions

氟嘧啶、奥沙利铂和曲氟尿苷替加氟方案输注持续时间是否影响胃癌围手术期治疗结局?比较24小时与48小时输注

2026-05-190
PRE
Correction: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer

更正:吉西他滨联合nab-紫杉醇在转移性胰腺癌二线治疗中的疗效

2026-04-030
OAAI
The effect of switching from ribociclib to palbociclib due to toxicity in hormone receptor-positive, HER2-negative metastatic breast cancer: a real-world, multicenter, retrospective study

因毒性作用将ribociclib换用palbociclib对激素受体阳性、HER2阴性转移性乳腺癌的影响:一项真实世界、多中心、回顾性研究

2026-03-260
OAAI
Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study

局部晚期直肠癌中总新辅助疗法的真实世界有效性:一项多中心回顾性研究

2026-03-230
OAAI
Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety

CDK4/6抑制剂治疗转移性乳腺癌患者的生存率影响因素:ER表达水平和治疗初治性的重要性

2025-12-170
OAAI
The efficacy of targeted therapies in metastatic squamous cell carcinoma of the lung: a Turkish Oncology Group multicentre study

靶向疗法在肺鳞状细胞癌转移中的疗效:一项土耳其肿瘤学组多中心研究

2025-12-010
PRE
Prognostic Effect of KELIM Score of Prostate-Specific Antigen in Hormone-Sensitive Prostate Cancer Patients Treated With Novel Androgen Receptor Inhibitors: Pioneering New Ways

激素敏感性前列腺癌患者接受新型雄激素受体抑制剂治疗后前列腺特异性抗原KELIM评分的预后效应:开创新途径

2025-11-010
OA
Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program

avelumab维持治疗在真实世界扩展性准入计划中的转移性尿路上皮癌患者中的应用

2025-10-160
PRE